跳至主要内容
临床试验/NCT01239589
NCT01239589已完成不适用

European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic Episodes Treated With Immediate Release Quetiapine or Extended Release Quetiapine

AstraZeneca1 个研究点 分布在 1 个国家目标入组 1,280 人开始时间: 2010年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
1,280
试验地点
1
主要终点
Length of hospital stay

研究概览

简要总结

This study is being carried out to find out how patients suffering from the acute manic phase of bipolar disease are currently managed with Quetiapine Immediate Release (IR) or Quetiapine Extended Release (XR) in the hospital setting in real life practice, including length of stay.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with Bipolar Disorder (ICD-10).
  • Admitted for acute bipolar manic episode from 1st October 2009 to 1st October 2010
  • Patients treated with quetiapine IR or quetiapine XR during the hospitalization period.

排除标准

  • Patients in which BD is not the main reason for hospitalization
  • Patients admitted for acute bipolar mania episodes but finally diagnosed with mixed or bipolar disorder not otherwise specified (NOS) episodes
  • Patients receiving both quetiapine IR and XR during the same hospitalization period.

结局指标

主要结局

Length of hospital stay

次要结局

  • Use of resources
  • Treatments used
  • Demographics

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验